Submission Details
| 510(k) Number | K222972 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 27, 2022 |
| Decision Date | August 25, 2023 |
| Days to Decision | 332 days |
| Submission Type | Traditional |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
Cleared
Traditional
BioProtect Balloon Implant? System
Aug 2023
Decision
332d
Days
Class 2
Risk
About This 510(k) Submission
K222972 is an FDA 510(k) clearance for the BioProtect Balloon Implant? System, a Hydrogel Spacer (Class II — Special Controls, product code OVB), submitted by Bioprotect, Ltd. (Tzur Yigal, IL). The FDA issued a Cleared decision on August 25, 2023, 332 days after receiving the submission on September 27, 2022. This device falls under the Radiology review panel. Regulated under 21 CFR 892.5725.
Device Classification
| Product Code | OVB — Hydrogel Spacer |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 892.5725 |
| Definition | The Perirectal Spacer Is Intended To Temporarily Position The Anterior Rectal Wall Away From The Prostate During Radiotherapy For Prostate Cancer And In Creating This Space It Is The Intent Of The Perirectal Spacer To Reduce The Radiation Dose Delivered To The Anterior Rectum. The Perirectal Spacer Is Composed Of Biodegradable Material And Maintains Space For The Entire Course Of Prostate Radiotherapy Treatment And Is Completely Absorbed By The Patient?s Body Over Time. |
Manufacturer
Similar Devices — OVB Hydrogel Spacer
K260119 · Boston Scientific Corporation
· Feb 2026
K220641 · Palette Life Sciences
· May 2022
K202224 · Boston Scientific Corporation
· Aug 2020
K182971 · Augmenix, Inc.
· Jul 2019
K181465 · Augmenix, Inc.
· Jun 2018
DEN140030 · Augmenix, Inc.
· Apr 2015